:

Nishitha R Pillai1, Ning Liu2,3, Xiyuan Li2,3

  • 1Department of Pediatrics, Division of Genetics and Metabolism, University of Minnesota, Minneapolis, MN, USA. Pilla125@umn.edu.

Communications medicine
|January 9, 2025
PubMed
概括

造血细胞移植 (HCT) 对多重硫酶缺乏症 (MSD),一种罕见的神经退行性疾病,显示出有前途. 早期的结果表明,在接受HCT的患者中,生化改善和疾病进展放缓.